AHWB released its performance for the first three quarters, with a net profit attributable to the parent company of 33.1106 million yuan, a decrease of 57.44%Zhitong·Oct 22, 2025 at 06:46 AM301520+2.11%
The innovative drug concept fell at the beginning of the session, with Cosunter down 10%Zhitong·Jun 17, 2025 at 08:28 PM002550+0.15%000788+1.36%
The medical services sector has seen a short-term decline, with Kingchem falling over 8%Zhitong·Jun 4, 2025 at 08:33 PM301096+5.17%688222+4.98%
Ergothioneine receives attention, multiple listed companies respond to related questionsZhitong·May 17, 2025 at 09:13 PM301371+0.39%301520+2.11%
AHWB released its 2024 annual performance, with a net profit attributable to the parent company of 85.5307 million yuan, a decrease of 20.87%Zhitong·Apr 21, 2025 at 06:56 AM301520+2.11%
AHWB released its first-quarter performance, with a net profit attributable to the parent company of 11.8493 million yuan, a decrease of 60.09%Zhitong·Apr 21, 2025 at 06:51 AM301520+2.11%
AHWB plans to distribute a profit of 3.5 yuan for every 10 shares in the first three quartersZhitong·Dec 30, 2024 at 03:57 AM301520+2.11%
